Use of Letermovir for Cytomegalovirus Prophylaxis in Lung Transplant

Purpose: To evaluate the efficacy and safety of letermovir (LTV) compared to valganciclovir (VGC) for primary (1PPX) and secondary (2PPX) prophylaxis of cytomegalovirus (CMV) in lung transplant (LTX).

Source: The Journal of Heart and Lung Transplantation - April 1, 2024 Category: Transplant Surgery Authors: , J. Wang, N. Borkowski, B. Miner, M. Mahesri, M. Venkata Subramani, R. Tomic, A. Arunachalam, C. Myers Source Type: research